image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CN
$ 0.387
-10 %
$ 1.35 M
Market Cap
-0.11
P/E
CASH FLOW STATEMENT
-1.93 M OPERATING CASH FLOW
-2287.47%
26.4 K INVESTING CASH FLOW
314.77%
-2.62 M FINANCING CASH FLOW
-89.22%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis China SXT Pharmaceuticals, Inc.
image
Net Income -3.1 M
Depreciation & Amortization 203 K
Capital Expenditures -7.06 K
Stock-Based Compensation 352 K
Change in Working Capital -382 K
Others 1.16 M
Free Cash Flow -1.94 M

Cash Flow

Millions
Mar-2024 Mar-2023 Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
OPERATING CASH FLOW
Net Income (3.1) (5.9) (5.7) (2.7) (10.3) 1.5 1.2 1.2 0.1
Depreciation & Amortization 0.2 0.3 0.3 0.3 0.3 0.2 0.1 99.2 K 89 K
Deferred Income Tax 0 3.2 0.3 (0.2) (0.1) 7.72 K 5.85 K 0 0
Stock Based Compensation 0.4 0.6 2.3 0 0 0 0 0 0
Other Operating Activities 1.0 0.4 1.1 1.6 3.4 66.9 K 2 1.4 1.3
Change in Working Capital (0.4) 1.4 1.9 (1.6) 1.9 (1.5) 0.6 (1.0) 58.6 K
Cash From Operations (1.9) 80.8 K 0.3 (1.3) 0.9 0.2 1.9 0.3 0.2
INVESTING CASH FLOW
Capital Expenditures 7.06 K 70.7 K 62.5 K 93 K (0.4) (0.6) (1.1) (0.2) 97 K
Other Items 33.5 K 58.4 K 15.6 K (5.7) (5.1) 0 92.4 K 0 1.23 K
Cash From Investing Activities 26.4 K 12.3 K 46.9 K (5.8) (5.5) (0.6) (1.1) (0.2) 95.8 K
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0
Total Debt Repaid 1.3 4.0 2.8 (0.1) 8.8 69.5 K (0.3) 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities (3.9) (3.3) (4.3) 12.5 (5.8) 2.5 0 50.6 K (0.1)
Cash From Financing Activities (2.6) 2.9 1.6 12.4 3.0 9.0 (0.3) 50.6 K (0.1)
CHANGE IN CASH
Net Change In Cash (5.3) 1.8 2.2 6.1 (2.0) 8.6 0.5 54.1 K 43.9 K
FREE CASH FLOW
Free Cash Flow (1.9) (0.2) 0.2 (1.4) 0.5 (0.4) 0.9 0.1 85.5 K